Journal Article

A Quest for a Universal Plasma-Derived Antivenom Against All Elapid Neurotoxic Snake Venoms

Ratanabanangkoon, Kavi

2021

Overview

This review describes the research aimed at the development of universal antivenom against elapid neurotoxic snake venoms. The antivenoms produced in Thailand in the 1980s were of low potency, especially against the elapid venoms. This was thought to be due to the low immunogenicity of the α-neurotoxins, which are the most lethal toxins in these venoms. Comparisons of various α-neurotoxin conjugates and polymers, and also different immunological adjuvants, showed that the adjuvant used is the major determinant in the antibody response in horses. The potent Freund’s adjuvant was not used due to its severe local side-effect in horses. Therefore, a novel immunization protocol termed ‘low dose, low volume multi-site’ was developed for use in horses. This immunization protocol has led to the production of highly potent monospecific antivenoms against several elapid and viperid venoms, and two potent polyspecific antivenoms, one against 4 neurotoxic and another against 3 hematotoxic venoms. The immunization protocol has also led to other improvements in antivenom production including: several fold increases in antiserum potency, a reduction in the time required to reach therapeutically useful antibody titers, a 90% reduction in the amount of venom used, and 100% of the horses responding to the immunization program. This development is partly responsible for significant decrease in the Thailand’s annual snakebite death toll from a few dozens to mostly nil in recent years. Finally, a simple and novel immunization strategy, using a ‘diverse toxin repertoire’ composed of numerous elapid toxin fractions as immunogen, was proposed and tested. This immunization procedure has resulted in the successful production of a widely paraspecific antiserum against at least 36 neurotoxic venoms of 28 species encompassing 10 genera and from 20 countries on four continents, and possibly against all elapid venoms with α-neurotoxins as the lethal toxins. These results indicate that, with optimizations of the composition of the ‘diverse toxin repertoire’, the immunization scheme and antibody fractionation to increase the antivenom neutralizing potency, an effective universal antivenom against the neurotoxic elapid snakes of the world can be produced.

• Publisher: Frontiers Media SA,Frontiers Media S.A
• Subject: Adjuvants / Adjuvants, Immunologic - therapeutic use / Aldehydes / Animals / Antibodies / Antibody response / Antibody Specificity / Antisera / Antivenins - adverse effects / Antivenins - biosynthesis / Antivenins - therapeutic use / Antivenom / Clinical trials / Developing countries / diverse toxin repertoire / elapid snakes / Elapid Venoms - administration & dosage / Elapid Venoms - antagonists & inhibitors / Elapid Venoms - blood / Elapid Venoms - immunology / Elapidae / Epitopes / Horses / Horses - blood / Horses - immunology / Humans / Immunization / Immunogenicity / Immunology / LDCs / neurotoxic venoms / Neurotoxicity / Neurotoxins / Neurotoxins - administration & dosage / Neurotoxins - antagonists & inhibitors / Neurotoxins - blood / Neurotoxins - immunology / pan-specific antivenoms / Plasma / plasma-derived antivenoms / Polymerization / Snake bites / Snake Bites - drug therapy / Snake Bites - immunology / Snake Bites - metabolism / Tetanus / Toxicity / Toxins / Tropical diseases / universal antivenom / Venom